Strategic Project Management at the Project Level*

Kennedy, Tony

doi:10.1081/crp-100108181

Cited by 2 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These projects cannot be handled internally due to a lack of internal capacity or resources allowing streamlining processes. According to the literature review [3,8,11,12], this model is fading, but apparently not all outsourcing is strategic; contracts of both models continue to be employed relative to the company's specific requirements and outsourcing strategy. Companies see themselves as taking a more strategic, rather than tactical, or case-by-case, projectto-project approach to outsourcing with most planning to continue this approach.…”

Section: Introductionmentioning

confidence: 99%

Outsourcing of Regulatory Affairs Tasks in Pharmaceutical Companies—Why and What?

Gummerus

Airaksinen

Bengtström³

et al. 2015

J Pharm Innov

View full text Add to dashboard Cite

Purpose The purpose of this study was to investigate what kind of regulatory affairs tasks is outsourced in the pharmaceutical industry and what are the reasons for outsourcing in the EU countries. Methods The study was conducted as an e-mail survey in the pharmaceutical industry in Finland, Sweden, Estonia, Germany, and Spain, focusing on those companies that undertake regulatory affairs. Results The survey received 71 completed responses out of 147, a response rate of 48 %. The most outsourced tasks were related to translations of product information texts (75 % of the respondents). The principal reason for outsourcing regulatory affairs tasks to a Contract Research Organization (CRO) was the excessively heavy workload in the company's regulatory affairs. Also, outsourcing should be cost-effective. The fact that the CRO has experience and knowledge was seen as a very important requirement when choosing the CRO partner. Personal, individual contacts were mentioned in many of the open-ended responses as an essential criterion in the selection of the CRO. Conclusions This survey indicated that outsourcing in regulatory affairs will continue. The quality of the CRO has a significant role when the companies select their partner. The CRO has to assure uniform quality of their personnel knowledge and skills in regulatory affairs, i.e., when the person in charge of the outsourced task changes in the CRO. Practically all product development steps can be outsourced by hiring local and multinational CROs. The companies should plan the outsourcing carefully and compare possible CROs even if the company has no plans to outsource at present.

show abstract

Section: Introductionmentioning

confidence: 99%

Outsourcing of Regulatory Affairs Tasks in Pharmaceutical Companies—Why and What?

Gummerus

Airaksinen

Bengtström³

et al. 2015

J Pharm Innov

View full text Add to dashboard Cite

show abstract

“…The regulatory affairs expert must balance four concerns: patient safety, product efficacy, regulatory compliance and company profitability. The regulatory affairs expert should therefore be a member of the team deciding the regulatory and launch strategy [6].…”

Section: Introductionmentioning

confidence: 99%